Researching better treatment for Focal Segmental Glomerulosclerosis and Minimal Change Disease Research study
This study is testing three new treatments for people who have Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD).
https://thermh-prod.thirststudios.io/research/clinical-trials-research-studies/efficacy-and-safety-of-treatment-in-participants-with-primary-focal-segmental-glomerulosclerosis-or-minimal-change-diseaseAbout planned surgery at the RMH
Planned surgeries are booked in advance and prioritised based on clinical urgency. You need a referral to have a planned surgery or procedure at the Royal Melbourne Hospital.
https://thermh-prod.thirststudios.io/services/planned-surgery/about-planned-surgeryPrivacy of your medical records
Maintaining your privacy and the confidentiality of your personal information is important to us.
https://thermh-prod.thirststudios.io/your-care/hospital-care/your-hospital-stay/your-medical-records/privacy-of-your-medical-recordsThe STARLIGHT Study Research study
This trial is testing a study drug to see if it can safely reduce the harmful effects of alcohol on the liver.
https://thermh-prod.thirststudios.io/research/clinical-trials-research-studies/the-starlight-studyStudy to reduce heart risks in people on dialysis with diabetes or heart disease Research study
This is a dose-finding and cardiovascular outcomes study of the study treatment in adults with end-stage kidney disease (ESKD) undergoing dialysis
https://thermh-prod.thirststudios.io/research/clinical-trials-research-studies/posibil6eskdKidney transplant desensitisation study for people on waiting lists Research study
This study is testing a treatment to see if it can lower antibodies in people on the kidney transplant waiting list.
https://thermh-prod.thirststudios.io/research/clinical-trials-research-studies/kidney-transplant-desensisitsation-study-for-people-on-waiting-listsResidential In Reach Post Hospital Support
Our Residential In Reach Post Hospital Support service can help patients to safely transition from a hospital admission to a Residential Aged Care Home (RACH).
https://thermh-prod.thirststudios.io/services/community-services/rmh-residential-in-reach/post-hospital-supportAtumelnant in adult participants with classic Congenital Adrenal Hyperplasia Research study
The purpose of this study is to evaluate the effect of a potential new treatment for Congenital Adrenal Hyperplasia (CAH) called atumelnant and compare it to placebo treatment.
https://thermh-prod.thirststudios.io/research/clinical-trials-research-studies/atumelnant-in-adult-participants-with-classic-congenital-adrenal-hyperplasiaA clinical trial testing a new investigational medication for people living with Graves’ Disease Research study
The purpose of this study is to compare a potential new treatment with improved side effects compared to current therapies in people living with Graves’ Disease.
https://thermh-prod.thirststudios.io/research/clinical-trials-research-studies/graves-disease-studyONWARDS-11 Study Research study
This research study aims to get more information on how a weekly insulin (insulin icodec) helps in reducing blood sugar compared to insulin glargine, an insulin taken once daily, in adults with type 1 diabetes, who are also taking a mealtime insulin (insulin aspart).
https://thermh-prod.thirststudios.io/research/clinical-trials-research-studies/onwards-11-studyThe IMAGINATION study Research study
This study is for people with a kidney condition called IgA nephropathy (IgAN), especially those at risk of their condition getting worse.
https://thermh-prod.thirststudios.io/research/clinical-trials-research-studies/the-imagination-studyThe FORTE Study Research study
This study is to test the safety and effectiveness of FB102 in well-controlled coeliac disease (those on a strict gluten free diet) following a gluten consumption challenge.
https://thermh-prod.thirststudios.io/research/clinical-trials-research-studies/the-forte-studyThe TRANSCEND study – testing a new medicine for kidney transplant rejection Research study
This study is testing a new medication called felzartamab for people who have received a kidney transplant and developed a type of rejection called late antibody-mediated rejection (AMR).
https://thermh-prod.thirststudios.io/research/clinical-trials-research-studies/the-transcend-studyThe Royal Melbourne Hospital is committed to Our First Nations Health Unit is committed to improving the health and wellbeing of First Nations people through advocacy, education and support.
https://thermh-prod.thirststudios.io/your-care/supporting-you/first-nations-healthThe AMPA-VEGA 1 Study Research study
Tired of hiding your depression? If your current antidepressant medication(s) is/are not adequately improving symptoms of your major depressive disorder (MDD), you may be eligible for the AMPA-VEGA 1 STUDY. This study is researching an investigational medication to see if it is safe and whether it...
https://thermh-prod.thirststudios.io/research/clinical-trials-research-studies/the-ampa-vega-1-studyThe Elumina Study Research study
Almost 1 in 3 people diagnosed with depression – or Major Depressive Disorder (MDD) – do not notice an improvement in their symptoms after trying at least two of the antidepressant drugs available today. This is known as Treatment-Resistant Depression (TRD). The Elumina study is...
https://thermh-prod.thirststudios.io/research/clinical-trials-research-studies/vls-01-buccal-film